BACTERIAL AND VIRAL SPECIMEN COLLECTION MARKET ANALYSIS

Bacterial And Viral Specimen Collection Market Size and Trends

Global bacterial & viral specimen collection market is estimated to be valued at USD 19.85 Bn in 2024 and is expected to reach USD 47.56 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.3% from 2024 to 2031. Factors like increasing prevalence of infectious diseases, growing awareness regarding specimen collection techniques, and rapidly improving healthcare infrastructure and services across geographies can drive the market growth.

To learn more about this report, Request sample copy

Growing prevalence of infectious diseases

Rising prevalence of infectious diseases can drive the market growth. Various factors such as climate change, increased global travel and connectivity, rising antimicrobial resistance, aging population, and environmental degradation contribute to prevalence of infectious disease. As per the WHO, infectious diseases account for nearly 15 million deaths each year worldwide. There has been increase in incidences of many viral and bacterial illnesses that can have serious health and economic implications such as tuberculosis, influenza, hepatitis, HIV/AIDS, pneumonia and several vector-borne diseases.

With growing international travel and migration, diseases are also spreading across borders much rapidly than before. Outbreaks that may have remained contained locally in the past can now turn into global epidemics within weeks. This presents serious public health challenges. Overuse and misuse of antimicrobial drugs has led to many microbes developing resistance to available treatments. Drug-resistant infectious pathogens have emerged as one of the biggest threats facing humanity. All these factors reinforce the need for better infectious diseases surveillance, early detection, and prompt diagnosis worldwide. Rising population susceptibility due to factors such as aging, greater prevalence of chronic diseases and immunosuppression has also contributed to the higher infectious diseases burden. The elderly people and people with compromised immunity are at an elevated risk of infections. This underscores the importance of diligent specimen collection, targeted screening, and timely administration of appropriate treatments.

To learn more about this report, Request sample copy

Growing awareness about disease screening and diagnostic importance

In recent years, public understanding about the significance of regular health screening and early detection of illnesses has enhanced considerably. People are more informed now about how identifying infections early through appropriate tests can help receive prompt treatment and potentially avoid severe complications. There is growing realization that ignoring symptoms or delays in seeking medical attention can adversely impact health outcomes, especially for infectious diseases.

Various health awareness drives by governments and international agencies can drive the market growth. The advent of new diagnostic technologies and tests has boosted test accessibility and affordability in significant parts of the world. The COVID-19 pandemic, in particular, highlighted the value of diagnostic testing and highlighted how expanded testing capacity and infrastructure are vital for addressing public health emergencies. It underscored the need for continuous disease monitoring to quickly identify new outbreaks. Deadly infectious disease outbreaks in the past like Zika and Ebola outbreak accentuated the indispensable role of accurate and timely diagnosis. Rising health insurance penetration and availability of subsidized screening programs for sections of population have additionally boosted screening uptake. Growing recognition and emphasis on prevention and early detection of illnesses aid the expansion of bacterial & viral specimen collection market. With enhanced awareness, individuals are displaying greater proclivity for recommended medical checkups and tests.